Katherine Schreck, MD; Caroline Carlin, PhD; Jason Ricco, MD, MPH
Corresponding Author: Jason Ricco, MD, MPH; University of Minnesota Medical School - Department of Family Medicine and Community Health.
Contact Email: ricco004@umn.edu
Section: Brief Report
INTRODUCTION: Current research shows no increased risk of thromboembolic events with mild COVID-19, but does not account for comorbidities. The aim of this study was to examine the incidence of thromboembolic events, including pulmonary embolism, cerebral infarction, and deep vein thrombosis, in non-hospitalized patients diagnosed with COVID-19 while accounting for comorbidities such as diabetes, asthma, COPD and cancer.
METHODS: We completed a large retrospective observational analysis of adult patients within a large urban health system.
RESULTS: Utilizing a logit framework (with and without propensity score weighting), there was no increased risk of thromboembolic events among patients positive for SARS-CoV-2 who did not require hospitalization for COVID-19.
CONCLUSION: This data suggest prophylactic anticoagulation is likely not warranted in the outpatient setting.